We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Syncona

News List

Achilles' US IPO closed with proceeds of $175m pharmatimes
April 09, 2021
Cancer Research UK spinout Achilles Therapeutics has closed its Initial Public Offering in the US bagging gross proceeds of $175.5 million.
Syncona invests $80m in Freeline’s systemic disease gene therapies pharmaceutical-technology
December 23, 2019
Syncona has committed to investing $80m in gene therapy-focused Freeline’s Series C financing round.
Syncona powers gene therapy startup Freeline to £88M B round fiercebiotech
June 25, 2018
Syncona has dialed up its bet on gene therapy startup Freeline Therapeutics. The life science investor committed £85 million ($112 million) to Freeline’s £88 million series B round, thereby maintaining a big stake in a biotech that is working to redefine